Galen Partners is a leading healthcare growth equity, late stage venture capital firm that focuses on investments in healthcare technology-enabled services, medical devices and specialty pharmaceutical companies. Galen has invested in more than 70 companies since 1990 and has nearly $1 billion in assets under management. The firm leads investments of $10 million to $30 million of growth equity capital. Galen continues its tradition of strategic collaboration and active partnership with its portfolio company management teams to build healthcare market leaders.